Owing to the propensity for visual loss, immunosuppressive treatment in the form of systemic and/or local therapy is often required for the management of noninfective intermediate and posterior ...

An estimated 5% to 10% of blindness worldwide is due to the rare inflammatory eye disease uveitis. Intermediate uveitis is often associated with a chronic course of the disease and the need for ...

Please provide your email address to receive an email when new articles are posted on . Individually tailored immunosuppressive therapy may help preserve vision in at least one eye in children with ...

An estimated five to ten percent of blindness worldwide is due to the rare inflammatory eye disease uveitis. Intermediate uveitis is often associated with a chronic course of the disease and the need ...

Expert Rev Ophthalmol. 2012;7(6):587-594. Multiple sclerosis (MS) is a neurodegenerative disease that causes demyelination of the CNS. MS can cause a wide variety of neuro-ophthalmic manifestations ...

An investigational Janus kinase 1 (JAK1) preferential inhibitor reduced the risk of treatment failure among patients with active noninfectious uveitis, the phase II randomized HUMBOLDT trial showed.

Vitreous cysts are rare structural entities that have been reported sporadically in the literature. Several associations have been described, including retinitis pigmentosa, Toxoplasmosis, trauma, ...

STAINES-UPON-THAMES, United Kingdom, Oct. 26, 2018 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today confirmed screening of the first patient in ...

A 61-year-old woman presented with a 3-month history of floaters and decreased vision in her left eye. Her visual acuity was 6/7.5 and 6/18 in the right eye and left eye, respectively. Dilated ...

Carey said the take-home message is “if you have a patient who’s had MS and optic neuritis, and they call your office saying, ...